Showing 5,801 - 5,820 results of 81,797 for search '(( 50 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a d decrease ))', query time: 1.29s Refine Results
  1. 5801
  2. 5802
  3. 5803
  4. 5804
  5. 5805
  6. 5806

    C2GnT1 gene knock-down results in decreased binding of cells to E-selectin. by Catherine A. St. Hill (357388)

    Published 2013
    “…(D) In the same run of experiments, at a shear stress of 0.5 dynes/cm<sup>2</sup>, significantly fewer un-manipulated LS174T cells treated with a 10 µg/ml of a blocking anti-E-selectin mAb accumulated on E-selectin than those cells treated with an isotype control mAb, <sup>#</sup>p = 0.004. …”
  7. 5807
  8. 5808

    Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: by Vidya G. Bettada (22208808)

    Published 2025
    “…Ki67 on the other hand showed a significant reduction in the expression in the i.p & i.t treated vitamin D3 group. 7D. …”
  9. 5809

    Primary and Secondary antibodies used. by Vidya G. Bettada (22208808)

    Published 2025
    “…A dose-dependent decrease in the (a) number of proliferating cells; (b) viability and (c) an increase in apoptosis (as evidenced by increased cleaved caspase-3) were observed with vitamin D treatment. …”
  10. 5810
  11. 5811
  12. 5812
  13. 5813

    Image_1_Identification of a Compound That Inhibits the Growth of Gram-Negative Bacteria by Blocking BamA–BamD Interaction.TIFF by Yan Li (23143)

    Published 2020
    “…Moreover, our results suggest that IMB-H4 disrupts BamA–BamD interaction by binding to BamA. Strikingly, E. coli cells having been treated with IMB-H4 showed impaired OM integrity and decreased the abundance of OMPs. …”
  14. 5814

    Image_2_Identification of a Compound That Inhibits the Growth of Gram-Negative Bacteria by Blocking BamA–BamD Interaction.TIF by Yan Li (23143)

    Published 2020
    “…Moreover, our results suggest that IMB-H4 disrupts BamA–BamD interaction by binding to BamA. Strikingly, E. coli cells having been treated with IMB-H4 showed impaired OM integrity and decreased the abundance of OMPs. …”
  15. 5815

    Image_3_Identification of a Compound That Inhibits the Growth of Gram-Negative Bacteria by Blocking BamA–BamD Interaction.TIF by Yan Li (23143)

    Published 2020
    “…Moreover, our results suggest that IMB-H4 disrupts BamA–BamD interaction by binding to BamA. Strikingly, E. coli cells having been treated with IMB-H4 showed impaired OM integrity and decreased the abundance of OMPs. …”
  16. 5816

    Data_Sheet_1_Identification of a Compound That Inhibits the Growth of Gram-Negative Bacteria by Blocking BamA–BamD Interaction.docx by Yan Li (23143)

    Published 2020
    “…Moreover, our results suggest that IMB-H4 disrupts BamA–BamD interaction by binding to BamA. Strikingly, E. coli cells having been treated with IMB-H4 showed impaired OM integrity and decreased the abundance of OMPs. …”
  17. 5817

    Treatment with vitamin D3 differentially altered the expression of cell death and proliferation markers in Hep 3B and HCT 116 cell lines <i>To determine the impact of vitamin D3 tr... by Vidya G. Bettada (22208808)

    Published 2025
    “…<p>5A & 5B. Analysis of the blots revealed that treatment of Hep 3B cells for 24h with increasing vitamin D3 concentration increased the VDR expression in both the cell lines. …”
  18. 5818
  19. 5819

    Table 2_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”
  20. 5820

    Table 1_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”